INS and diabetes mellitus: For nonresponders to IGlar who have reached FBG target or whose up-titration of IGlar dose is limited by the frequency and/or severity of hypoglycemia, diabetes treatment should be intensified with PPG-lowering agents, such as prandial insulin or GLP1-RA.